| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 5.301 | 19.105 | 17.068 | 13.997 | 16.027 | 20.717 | 23.407 | 29.768 |
| Total Income - EUR | - | - | 5.301 | 19.105 | 17.068 | 13.997 | 16.027 | 20.717 | 23.407 | 30.811 |
| Total Expenses - EUR | - | - | 76 | 321 | 472 | 334 | 206 | 299 | 5.419 | 5.841 |
| Gross Profit/Loss - EUR | - | - | 5.225 | 18.784 | 16.596 | 13.663 | 15.822 | 20.419 | 17.988 | 24.970 |
| Net Profit/Loss - EUR | - | - | 5.066 | 18.211 | 16.084 | 13.273 | 15.350 | 19.809 | 15.312 | 21.314 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Medcord Dr. Moise Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 60 |
| Current Assets | - | - | 5.534 | 22.150 | 37.484 | 50.044 | 64.270 | 20.396 | 35.738 | 57.092 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 367 | 1.127 | 0 | 0 | 1.697 | 3.900 | 1.806 |
| Cash | - | - | 5.534 | 21.783 | 36.358 | 50.044 | 64.270 | 18.699 | 31.838 | 55.286 |
| Shareholders Funds | - | - | 5.110 | 18.349 | 34.077 | 46.704 | 61.019 | 20.184 | 35.435 | 56.551 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 424 | 3.801 | 3.411 | 3.344 | 3.255 | 217 | 744 | 1.105 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medcord Dr. Moise Srl